{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:35:36Z","timestamp":1793262936995,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jiac.2026.103108","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:27:19Z","timestamp":1792510039000},"page":"103108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Appropriate administration of tazobactam\/piperacillin for urinary and genital tract infections based on antibiotic susceptibility testing: a single-center retrospective analysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Yuichiro","family":"Hishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-2225","authenticated-orcid":false,"given":"Yoshiki","family":"Hiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaka","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-4554","authenticated-orcid":false,"given":"Kentaro","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.103108_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2023.08.009","article-title":"Urinary tract infections: core curriculum 2024","volume":"83","author":"Al Lawati","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jiac.2026.103108_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/14787210.5.3.365","article-title":"Piperacillin-tazobactam: a beta-lactam\/beta-lactamase inhibitor combination","volume":"5","author":"Gin","year":"2007","journal-title":"Expert Rev Anti-infect Ther"},{"key":"10.1016\/j.jiac.2026.103108_bib3","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/cid\/ciz668","article-title":"Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection: a multisite retrospective study","volume":"70","author":"Babich","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.103108_bib4","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/j.ijid.2013.01.030","article-title":"The impact of the increased use of piperacillin\/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates","volume":"17","author":"Lee","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2026.103108_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.25252","article-title":"Antibiotic use and the risk of hospital-onset Clostridioides difficile infection","volume":"8","author":"Gilboa","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiac.2026.103108_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jiac.2024.03.024","article-title":"Fourth national Japanese antimicrobial susceptibility pattern surveillance program: bacterial isolates from patients with complicated urinary tract infections","volume":"30","author":"Kobayashi","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103108_bib7","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1128\/AAC.05984-11","article-title":"MurAA is required for intrinsic cephalosporin resistance of Enterococcus faecalis","volume":"56","author":"Vesi\u0107","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103108_bib8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2026.103108_bib9","series-title":"Japanese association for infectious diseases, Japanese society of chemotherapy","first-page":"p280","article-title":"Urinary tract infections","author":"Shingo","year":"2023"},{"key":"10.1016\/j.jiac.2026.103108_bib10","article-title":"Clinical practice guideline by infectious diseases society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: selection of antibiotic therapy for complicated uti","author":"Trautner","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.103108_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European association of urology guidelines on urological infections: summary of the 2024 guidelines","volume":"86","author":"Kranz","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.jiac.2026.103108_bib12","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.3889\/oamjms.2019.684","article-title":"Risk factors for catheter-associated urinary tract infection and uropathogen bacterial profile in the intensive care unit in hospitals in Medan, Indonesia","volume":"7","author":"Anggi","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.jiac.2026.103108_bib13","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.3390\/ijms26189193","article-title":"Catheter-associated urinary tract infections: understanding the interplay between bacterial biofilm and antimicrobial resistance","volume":"26","author":"Tegegne","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiac.2026.103108_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2025.102624","article-title":"The incidence and risk factor for febrile urinary tract infection after robot-assisted laparoscopic radical cystectomy in bladder cancer patients","volume":"31","author":"Hiyama","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103108_bib15","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2019-0098","article-title":"A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options","volume":"6","author":"Elshamy","year":"2020","journal-title":"Future Sci OA"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26002060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26002060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:11:41Z","timestamp":1793261501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26002060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1341321X26002060"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103108","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriate administration of tazobactam\/piperacillin for urinary and genital tract infections based on antibiotic susceptibility testing: a single-center retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103108"}}